[Gesture accuracy recognition based on grayscale image of surface electromyogram signal and multi-view convolutional neural network].

This study aims to address the limitations in gesture recognition caused by the susceptibility of temporal and frequency domain feature extraction from surface electromyography signals, as well as the low recognition rates of conventional classifiers. A novel gesture recognition approach was proposed, which transformed surface electromyography signals into grayscale images and employed convolutional neural networks as classifiers. The method began by segmenting the active portions of the surface electromyography signals using an energy threshold approach.

Lower Limb Motion Recognition Based on sEMG and CNN-TL Fusion Model.

To enhance the classification accuracy of lower limb movements, a fusion recognition model integrating a surface electromyography (sEMG)-based convolutional neural network, transformer encoder, and long short-term memory network (CNN-Transformer-LSTM, CNN-TL) was proposed in this study. By combining these advanced techniques, significant improvements in movement classification were achieved. Firstly, sEMG data were collected from 20 subjects as they performed four distinct gait movements: walking upstairs, walking downstairs, walking on a level surface, and squatting.

A Fusion Dimension Reduction Method for the Features of Surface Electromyographic Signals.

Surface electromyographic signals (sEMG) usually have high-dimensional properties, and direct processing of these data consumes significant computational resources. Dimensionality reduction processing can reduce the dimension of the data and improve the real-time performance and response speed. This is especially important for application scenarios such as prosthetic control and rehabilitation training where rapid feedback is required.

Endovascular versus Surgical Lower Extremity Revascularization among Patients with Chronic Kidney Disease.

Introduction: Patients with chronic kidney disease (CKD) have a high prevalence of peripheral artery disease. How best to manage lower extremity peripheral artery disease remains unclear in this patient population. We therefore sought to compare the outcomes after endovascular versus surgical lower extremity revascularization among patients with CKD.

QTL identification, fine mapping, and marker development for breeding peanut (Arachis hypogaea L.) resistant to bacterial wilt.

A major QTL, qBWA12, was fine mapped to a 216.68 kb physical region, and A12.4097252 was identified as a useful KASP marker for breeding peanut varieties resistant to bacterial wilt.

Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer.

Non-small cell lung cancer remains a highly lethal malignancy. Using the tamoxifen inducible Hnf1b:CreER (H) transgenic mouse crossed to the LsL-Kras (K) transgenic mouse, we recently discovered that an Hnf1b positive cell type in the lung is sensitive to adenoma formation when expressing a mutant Kras allele. In these mice, we observe adenoma formation over a time frame of three to six months.

Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.

Feeding a high-fat diet (HFD) coupled with sugar, mimicking a Western diet, causes fatty liver disease in mice. Histamine induces biliary proliferation and fibrosis and regulates leptin signaling. Wild-type (WT) and l-histidine decarboxylase (Hdc) mice were fed a control diet or an HFD coupled with a high fructose corn syrup equivalent.

Prostaglandin E2 Indicates Therapeutic Efficacy of Mesenchymal Stem Cells in Experimental Traumatic Brain Injury.

Traumatic brain injury (TBI) is soon predicted to become the third leading cause of death and disability worldwide. After the primary injury, a complex set of secondary injuries develops hours and days later with prolonged neuroinflammation playing a key role. TBI and other inflammatory conditions are currently being treated in preclinical and clinical trials by a number of cellular therapies.